These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6267844)

  • 1. [Duration of efficiency of pertussis immunoglobulin in the passive protection tests in mice (author's transl)].
    Sabin S; Schwanig M; Schneider W
    Zentralbl Bakteriol A; 1981; 249(2):254-60. PubMed ID: 6267844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Passive protection tests in the mouse with pertussis immunoglobulin (author's transl)].
    Sabin S; Schwanig M
    Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):268-74. PubMed ID: 228513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency testing of pertussis immunoglobulins, relationship between neutralisation test and agglutination test.
    Schneider W; Sabin S; Schwanig M
    Dev Biol Stand; 1979; 44():125-8. PubMed ID: 575633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine-sensitising factor of Bordetella pertussis differentiated from immunogens by neutralisation and passive protection tests.
    Preston NW; Garrity P
    J Pathol Bacteriol; 1967 Apr; 93(2):483-92. PubMed ID: 4293307
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitoxin in human pertussis immune globulins.
    Ferngren H; Granström M
    J Biol Stand; 1986 Oct; 14(4):297-303. PubMed ID: 2881931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Protective activity of whooping-cough convalescent serum and serum-IgA level in mice infected with Bordetella pertussis.
    Pittman M
    Lancet; 1976 Jul; 2(7977):156. PubMed ID: 59233
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
    Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
    Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vertical transmission of immunity against B. pertussis].
    Tripodi V; Liguori G; Capunzo M; D'Eliseo R
    Boll Ist Sieroter Milan; 1988; 67(5-6):357-62. PubMed ID: 2908739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits of using diverse animal models for studying pertussis.
    Elahi S; Holmstrom J; Gerdts V
    Trends Microbiol; 2007 Oct; 15(10):462-8. PubMed ID: 17920273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
    Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ
    J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serotyping of recently isolated strains of Bordetella pertussis. II. Disparity of agglutination titers of patients' sera between antigens prepared from the Maeno and recently isolated strains (author's transl)].
    Sekiya K; Yamada M; Takamiya A; Nakase Y
    Nihon Saikingaku Zasshi; 1979 Nov; 34(6):827-35. PubMed ID: 231129
    [No Abstract]   [Full Text] [Related]  

  • 12. Passive protection of mice with the 19 S and 7 S fractions of anti-pertussis sera in experiment.
    Stanislavskii ES; Beilina VB
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(3):301-8. PubMed ID: 203627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis.
    Dolby JM; Dolby DE
    Immunology; 1969 Jun; 16(6):737-47. PubMed ID: 4306784
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of serum anti-Bordetella pertussis antibody titers among medical staff members.
    Higa F; Haranaga S; Tateyama M; Hibiya K; Yamashiro T; Nakamatsu M; Tomoyose T; Nagahama M; Okamura T; Owan T; Kuda T; Kinjo F; Fujita J
    Jpn J Infect Dis; 2008 Sep; 61(5):371-4. PubMed ID: 18806344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies.
    Rodríguez ME; Hellwig SM; Pérez Vidakovics ML; Berbers GA; van de Winkel JG
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):39-47. PubMed ID: 16420595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
    Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
    Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic response and antibody-titer decay in adults with pertussis.
    Heininger U; Cherry JD; Stehr K
    Clin Infect Dis; 2004 Feb; 38(4):591-4. PubMed ID: 14765356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive and active immunity in whooping-cough in youngest children.
    Pstragowska W
    Pol Med J; 1966; 5(5):1103-8. PubMed ID: 5958797
    [No Abstract]   [Full Text] [Related]  

  • 19. A new animal model of Bordetella pertussis infection and immunity.
    Foreman-Wykert AK; Miller JF
    Trends Microbiol; 2005 Dec; 13(12):559-60. PubMed ID: 16223585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin.
    Medeiros MA; Armôa GR; Dellagostin OA; McIntosh D
    Can J Microbiol; 2005 Dec; 51(12):1015-20. PubMed ID: 16462859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.